1. Home
  2. IOVA vs STKL Comparison

IOVA vs STKL Comparison

Compare IOVA & STKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • STKL
  • Stock Information
  • Founded
  • IOVA 2007
  • STKL 1973
  • Country
  • IOVA United States
  • STKL United States
  • Employees
  • IOVA N/A
  • STKL N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • STKL Precious Metals
  • Sector
  • IOVA Health Care
  • STKL Basic Materials
  • Exchange
  • IOVA Nasdaq
  • STKL Nasdaq
  • Market Cap
  • IOVA 771.4M
  • STKL 694.7M
  • IPO Year
  • IOVA N/A
  • STKL N/A
  • Fundamental
  • Price
  • IOVA $1.88
  • STKL $6.26
  • Analyst Decision
  • IOVA Buy
  • STKL Strong Buy
  • Analyst Count
  • IOVA 10
  • STKL 2
  • Target Price
  • IOVA $12.22
  • STKL $9.50
  • AVG Volume (30 Days)
  • IOVA 10.5M
  • STKL 817.8K
  • Earning Date
  • IOVA 08-07-2025
  • STKL 08-06-2025
  • Dividend Yield
  • IOVA N/A
  • STKL N/A
  • EPS Growth
  • IOVA N/A
  • STKL N/A
  • EPS
  • IOVA N/A
  • STKL N/A
  • Revenue
  • IOVA $212,679,000.00
  • STKL $740,934,000.00
  • Revenue This Year
  • IOVA $86.62
  • STKL $10.78
  • Revenue Next Year
  • IOVA $69.95
  • STKL $8.39
  • P/E Ratio
  • IOVA N/A
  • STKL N/A
  • Revenue Growth
  • IOVA 11070.12
  • STKL 12.92
  • 52 Week Low
  • IOVA $1.64
  • STKL $3.65
  • 52 Week High
  • IOVA $12.51
  • STKL $8.11
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 47.47
  • STKL 56.23
  • Support Level
  • IOVA $1.68
  • STKL $6.15
  • Resistance Level
  • IOVA $2.02
  • STKL $6.66
  • Average True Range (ATR)
  • IOVA 0.11
  • STKL 0.28
  • MACD
  • IOVA 0.03
  • STKL 0.03
  • Stochastic Oscillator
  • IOVA 61.42
  • STKL 56.99

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About STKL SunOpta Inc.

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada and Others, out of which it derives maximum revenue from U.S.

Share on Social Networks: